ArticleInternational journal of nanomedicine2026
Graphene Oxide Potentiates Induction Efficiency and Functional Maturation of Induced Mammary Epithelial Cells.
Article in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to explore the effects of graphene oxide (GO) particles on the RepSox-mediated transdifferentiation of fibroblasts into mammary epithelial cells. Methods: GO was synthesized using the Hummers method, and its structure was characterized by Fourier transform infrared spectroscopy (FTIR) and Raman spectroscopy. Its biocompatibility was verified through CCK - 8 and EdU assays. The effects of the GO/RepSox composite system on the transdifferentiation process of fibroblasts and the potential regulatory mechanisms were comprehensively evaluated using morphological observation, immunofluorescent staining, Western blot analysis, real - time quantitative PCR (qRT - PCR), and RNA sequencing techniques. Results: The synthesized GO not only had good biocompatibility but also promoted cell proliferation. GO significantly improved the efficiency of RepSox-mediated transdifferentiation of fibroblasts into mammary epithelial cells and enhanced the lactation function of mammary epithelial cells. Mechanistically, GO may create favorable conditions for transdifferentiation by coordinately regulating mitochondrial energy metabolism (the ATP level was significantly increased in the R + GO group) and cell cycle progression (the proportion of cells in the G1 phase was significantly increased). Conclusion: This study first elucidates the regulatory role of GO in cell fate determination and provides innovative research ideas and experimental evidence for the application of nanomaterials in cell reprogramming and transdifferentiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.